Does PALBOCICLIB Cause Increased appetite? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Increased appetite have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
108
Reports of Increased appetite with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
3
Deaths
17
Hospitalizations
How Dangerous Is Increased appetite From PALBOCICLIB?
Of the 108 reports, 3 (2.8%) resulted in death, 17 (15.7%) required hospitalization.
Is Increased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Increased appetite?
SEMAGLUTIDE (980)
RISPERIDONE (808)
TIRZEPATIDE (640)
OLANZAPINE (556)
ARIPIPRAZOLE (465)
QUETIAPINE (389)
RUXOLITINIB (287)
PREDNISONE (265)
PREGABALIN (265)
GABAPENTIN (253)
Which PALBOCICLIB Alternatives Have Lower Increased appetite Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID